Home > Riviste > Minerva Surgery > Fascicoli precedenti > Articles online first > Minerva Surgery 2022 Mar 01

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Surgery 2022 Mar 01

DOI: 10.23736/S2724-5691.22.09314-5

Copyright © 2022 EDIZIONI MINERVA MEDICA

lingua: Inglese

Veno-venous extracorporeal membrane oxygenation used as an adjunct in the surgical management of acquired and iatrogenic tracheobronchial pathology

Tom EADINGTON 1 , Marcus TAYLOR 1, Rajesh SHAH 1, Felice GRANATO 1, Rajamiyer VENKATESWARAN 1, Lajos SZENTGYORGYI 2

1 Department of Cardiothoracic Surgery, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK; 2 Department of Cardiothoracic Anaesthesia, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK


PDF


BACKGROUND: Surgical repair of tracheobronchial tree injuries is challenging due to the difficulties associated with providing perioperative ventilatory support. Veno-venous extracorporeal membrane oxygenation (V-V ECMO) is a recognised treatment modality for managing respiratory failure. Its use has expanded to include offering respiratory support for patients requiring surgery on the tracheobronchial tree. This study presents our experience with V-V ECMO support for elective and emergency surgery for acquired and iatrogenic tracheobronchial pathology.
METHODS: A retrospective review of our single-centre experience of surgical tracheobronchial repairs where V-V ECMO was employed between 2017 and 2020 was undertaken. Preoperative patient characteristics, intra-operative findings, details of ECMO support and postoperative outcomes were collected and analysed.
RESULTS: Five patients underwent surgery with V-V ECMO support during the study period. Indications for surgery included repair of iatrogenic tracheal tear (n=2), repair of iatrogenic gastro-bronchial fistula (n=1), elective tracheoplasty (n=1) and elective resection of tracheal tumour (n=1). The median duration of V-V ECMO was 17 hours (range 4-543 hours), and the median postoperative length of stay was 9 days (range 7-19 days). In-hospital and 90-day mortality were both 0% (n=0). Post-operative complications included reoperation for bleeding (n=1) and thrombotic complications (n=2).
CONCLUSIONS: We have shown how V-V ECMO can be safely utilised to manage patients with a range of tracheobronchial injuries with low rates of postoperative morbidity. Acceptable postoperative outcomes can be achieved for this cohort of clinically complex patients when treatment is provided with a multidisciplinary team approach in high-volume specialist centres.


KEY WORDS: V-V ECMO; Thoracic surgery; Tracheobronchial; Iatrogenic; 90-day mortality

inizio pagina